Kangjian International Healthcare (03886) issued an announcement. It is expected that the Group will split the year ended December 31, 2023...
According to the Zhitong Finance App, Health International Healthcare (03886) announced that it is expected that the Group will each obtain a comprehensive loss attributable to shareholders of approximately HK$165 million to HK$223 million and a comprehensive loss of approximately HK$135 million to HK$183 million for the year ended December 31, 2023, while achieving a comprehensive profit attributable to shareholders of approximately HK$15.3 million and comprehensive profit of approximately HK$49.5 million respectively for the year ended 31 December 2022. The significant change from shareholders' consolidated profit to shareholders' comprehensive loss was mainly due to the net impact of (i) (a) increased demand for medical services and medical network management services and mainland hospital management services due to the rebound after the coronavirus pandemic; and (b) the contribution of Central Medical Holdings Limited after being acquired by the Group in August 2022, which increased the Group's revenue for the year ended 31 December 2023, while the Group achieved revenue for the year ended 31 December 2022 Approximately HK$1,536 million; (ii) the Group experienced a significant increase in fair value losses for the year ended 31 December 2023, while the fair value loss was approximately HK$6.9 million for the year ended 31 December 2022; and (iii) the impairment losses recognized for the Group's various assets increased significantly in the year ended 31 December 2023, while impairment losses of approximately HK$4.9 million were recorded for the year ended 31 December 2022.
The Group is currently evaluating and valuing its related assets. After the Group obtains the final results of the relevant evaluation and valuation, the Group may make further adjustments to the amount of relevant assets for the year ended 31 December 2023.